‘Mystical’ psychedelic compound found in normal brains… Do Our Brains Produce DMT? A Natural Source of DMT Has Been Discovered in Mammal Brains… … Millsian Inc molecular modelling!

“Ha! I just started reading DMT The Spirit Molecule : A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences (Dr Rick Strassman).”

‘The Spirit Molecule’… the most powerful psychedelic compound known to humans! 😀

My interest (aside from taking the stuff in the form of Ayahuasca) is… 😀
You know what’s coming!

Millsian Inc. The Future of Molecular Modelling
Millsian, Inc., is the future of molecular modeling. Utilizing a new classical approach to solving atoms and molecules, our software will help researchers design the next generation of pharmaceuticals.
Millsian, Inc. is dedicated to developing the molecular modeling applications of The Grand Unified Theory of Classical Physics (GUT-CP), solving atomic and molecular structures by applying the classical laws of physics (Newton’s and Maxwell’s Laws) to the atomic scale.
The functional groups of all major classes of chemical bonding, including those involved in most organic molecules, have been solved exactly in closed-form solutions. By using these functional groups as building blocks, or independent units, a potentially infinite number of molecules can be solved. As a result, Millsian software can visualize the exact three-dimensional structure and calculate physical characteristics of almost any molecule of any length and complexity. While previous software based on traditional quantum methods resorted to approximations and required super computers for even simple systems, Millsian software requires no special expertise to solve complex proteins and DNA on a personal computer.
The Millsian competitive advantage includes rendering true molecular structures providing precise bonding characteristics, spatial and temporal charge distributions, and energies of every electron in every bond and bonding atom, facilitating the identification of biologically active sites in drugs; and facilitating drug design. The Company believes that this represents a major breakthrough in material science that has the potential to impact nearly all businesses involved in drug development and chemistry.

‘Mystical’ psychedelic compound found in normal brains

by University of Michigan

rat brain
Cerebellum of CIVM postnatal rat brain atlas. Credit: Neurolex

In the past few years, thrill-seekers from Hollywood, Silicon Valley and beyond have been travelling to South America to take part in so-called Ayahuasca retreats. Their goal: to partake in a brewed concoction made from a vine plant Banisteriopsis caapi, traditionally used by indigenous people for sacred religious ceremonies. Drinkers of Ayahuasca experience short-term hallucinogenic episodes many describe as life-changing.

The active ingredient responsible for these psychedelic visions is a molecule called dimethyltryptamine (DMT). For the first time, a team led by Michigan Medicine has discovered the widespread presence of naturally-occurring DMT in the mammalian brain. The finding is the first step toward studying DMT— and figuring out its role—within the brains of humans.

“DMT is not just in plants, but also can be detected in mammals,” says Jimo Borjigin, Ph.D., of the Department of Molecular and Integrative Physiology. Her interest in DMT came about accidentally. Before studying the psychedelic, her research focused on melatonin production in the pineal gland.

In the seventeenth century, the philosopher Rene Descartes claimed that the pineal gland, a small pinecone-shaped organ located deep in the center of the brain, was the seat of the soul. Since its discovery, the pineal gland, known by some as the third eye, has been shrouded in mystery. Scientists now know it controls the production of melatonin, playing an important role in modulating circadian rhythms, or the body’s internal clock. However, an online search for notes to include in a course she was teaching opened Borjigin’s eyes to a thriving community still convinced of the pineal gland’s mystical power.

The core idea seems to come from a documentary featuring the work of researcher Rick Strassman, Ph.D. with the University of New Mexico School of Medicine. In the mid-1990s, he conducted an experiment in which human subjects were given DMT by IV injection and interviewed after its effects wore off. In a documentary about the experiment, Strassman claims that he believed the pineal gland makes and secretes DMT.

“I said to myself, ‘wait, I’ve worked on the pineal gland for years and have never heard of this,'” she said. She contacted Strassman, requesting the source of his statement. When Strassman admitted that it was just a hypothesis, Borjigin suggested they work together to test it. “I thought if DMT is an endogenous monoamine, it should be very easy to detect using a fluorescence detector.”

Using a process in which microdialysis tubing is inserted into a rat brain through the pineal gland, the researchers collected a sample that was analyzed for—and confirmed—the presence of DMT. That experiment resulted in a paper published in 2013.

However, Borjigin was not satisfied. Next, she sought to discover how and where DMT was synthesized. Her graduate student, Jon Dean, lead author of the paper, set up an experiment using a process called in situ hybridization, which uses a labeled complementary strand of DNA to localize a specific RNA sequence in a tissue section.

“With this technique, we found brain neurons with the two enzymes required to make DMT,” says Borjigin. And they were not just in the pineal gland.

“They are also found in other parts of the brain, including the neocortex and hippocampus that are important for higher-order brain functions including learning and memory.”

The results are published in the journal Scientific Reports.

Her team’s work has also revealed that the levels of DMT increase in some rats experiencing cardiac arrest. A paper published in 2018 by researchers in the U.K. purported that DMT simulates the near death experience, wherein people report the sensation of transcending their bodies and entering another realm. Borjigin hopes to probe further to discover the function of naturally occurring levels of DMT in the brain—and what if any role it plays in normal brain functions.

“We don’t know what it’s doing in the brain. All we’re saying is we discovered the neurons that make this chemical in the brain, and they do so at levels similar to other monoamine neurotransmitters.”

A Natural Source of DMT Has Been Discovered in Mammal Brains 

Scientists detected DMT “at the levels sufficient to contribute to brain functions” in rats. 


By Emma Betuel on June 27, 2019Filed Under Death, Neuroscience & Psychology

Humans have cultivated a complicated relationship with DMT, labeling it as both a dangerous drug and “the spirit molecule.” Now, a growing body of evidence shows that mammals’ brains may manufacture significant amounts of DMT all on their own, indicating that we may be even more intimately tied to the molecule than we thought.

DMT, short for N,N-dimethyltryptamine, is one of the main active compounds in ayahuasca, a psychoactive brew that has been used in religious rituals in Ecuador, Columbia, Peru, and Brazil for hundreds of years. More recently, the molecule has become the focus of ongoing research on mood and post-traumatic stress disorder treatments. New evidence suggests that not only do human brains respond to DMT but that they may even produce it.

In a paper published Thursday in the journal Scientific Reports, a team of scientists at the University of Michigan shows that the mammal brain has the tools it needs to manufacture DMT. The evidence that the mammal brain is capable of making its own DMT is “very strong in rats and humans,” the study’s corresponding author Jimo Borjigin, Ph.D., tells Inverse.

Crystals of DMT imaged with polarizing microscopy. Scientists now believe that DMT can also be produced naturally in mammal brains. 

Do We Produce Endogenous DMT?

The idea that mammal brains produce endogenous DMT can be traced to Rick Strassman, M.D. As a clinical psychiatrist at the University of New Mexico, Strassman ran a series of experiments in the 1990s that led to his book (and later documentary) DMT: The Spirit Molecule, in which he proposed that DMT can be naturally secreted by the brain’s pineal gland in high enough quantities to induce mystical experiences.

In 2013, Borjigin’s lab detected signs of DMT in the pineal glands of rats. However, the idea that endogenous DMT reached that level in humans is still contested.

In her new work, Borjigin argues there’s evidence we do indeed produce enough DMT to be biologically relevant.

“DMT is naturally made and released in mammalian brains at the levels sufficient to contribute to brain functions,” she says. The key, though, is that she believes it’s not only the pineal gland that’s responsible for DMT manufacturing.

In this paper, Borjigin and her team describe the results of an experiment in which they induced cardiac arrest in rats and then measured the levels of two chemicals involved in the synthesis of DMT. The researchers also examined brain tissues from human cadavers for these chemicals. They note that the human brains contained one of them, while the rat brains contained two of the enzymes that are required to make DMT, not only in the pineal gland, but also in the cerebral cortex and the hippocampus. Unlike Strassman’s work suggests, she believes that it’s probably not the pineal gland driving DMT synthesis in rat brains.

“DMT synthesis was thought to take place outside of the brain, but we show the presence of DMT synthetic enzymes in the brain; in fact our data suggest DMT production is most likely from non-pineal cells of the brain,” she explains.

Dimethyltryptamine (DMT) is considered a classic psychedelic drug.

DMT and the Near Death Experience

Armed with the idea that the brain has the tools it needs to manufacture DMT, Borjigin also set out to investigate one of Strassman’s bigger claims: that DMT has strong ties to the psychological experiences that accompany death, or close brushes with it. Her work was done in mice, but there has been recent, ongoing work that focuses on humans. DMT is naturally made and released in mammalian brains at the levels sufficient to contribute to brain functions.”

What we do know is that when humans are injected with DMT it can induce out-of-body sensations. One human study illustrating that effect was released in August 2018 in Frontiers in Psychology. That paper found that people who received DMT injections had experiences that bore strong similarities to those reported by people who had actual near death experiences, including the sensation of transcending their body.

One participant described the sensation as a feeling that the body “doesn’t feel relevant anymore.”

Borjigin’s paper is primarily a rat study, so there are no anecdotal accounts of transcendence. But she did note that some rats showed surges in the levels of DMT in their brains when they experienced cardiac arrest, which was induced by the researchers as part of the experiment. Crucially, this happened even in rats whose pineal gland had been removed.

“DMT rises in a subset of rats during cardiac arrest, but not in all rats,” she notes, suggesting the need for further study to figure out why only some expressed the molecule.

It’s a long way to connect the dots between human experiences of death and a spike in DMT in the brains of rats experiencing heart failure. Borjigin’s work is intended to push the needle a bit further along on an idea that once seemed outlandish: Rat brains, at least, have all the tools to manufacture DMT on their own, though it’s still a mystery as to what actually happens once the process gets going.

Abstract: N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and periphery, and brain concentrations of DMT in rats. INMT transcripts were identified in the cerebral cortex, pineal gland, and choroid plexus of both rats and humans via in situ hybridization. Notably, INMT mRNA was colocalized with AADC transcript in rat brain tissues, in contrast to rat peripheral tissues where there existed little overlapping expression of INMT with AADC transcripts. Additionally, extracellular concentrations of DMT in the cerebral cortex of normal behaving rats, with or without the pineal gland, were similar to those of canonical monoamine neurotransmitters including serotonin. A significant increase of DMT levels in the rat visual cortex was observed following induction of experimental cardiac arrest, a finding independent of an intact pineal gland. These results show for the first time that the rat brain is capable of synthesizing and releasing DMT at concentrations comparable to known monoamine neurotransmitters and raise the possibility that this phenomenon may occur similarly in human brains.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s